Details for Patent: 8,648,106
✉ Email this page to a colleague
Which drugs does patent 8,648,106 protect, and when does it expire?
Patent 8,648,106 protects PRECEDEX and is included in one NDA.
Protection for PRECEDEX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-one patent family members in thirty-five countries.
Summary for Patent: 8,648,106
| Title: | Dexmedetomidine premix formulation |
| Abstract: | The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation. |
| Inventor(s): | Roychowdhury; Priyanka (Foster City, CA), Cedergren; Robert A. (Libertyville, IL) |
| Assignee: | Hospira, Inc. (Lake Forest, IL) |
| Application Number: | 13/867,861 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,648,106 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
More… ↓ |
Drugs Protected by US Patent 8,648,106
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-004 | Nov 14, 2014 | AP | RX | Yes | Yes | 8,648,106*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-002 | Mar 13, 2013 | AP | RX | Yes | Yes | 8,648,106*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-003 | Mar 13, 2013 | AP | RX | Yes | Yes | 8,648,106*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,648,106
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 089673 | ⤷ Subscribe | |||
| Argentina | 117001 | ⤷ Subscribe | |||
| Australia | 2013201069 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
